Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis [Breast Cancer]
Conclusion
Our findings in a largely unadjusted analysis suggest that overweight and obesity are risk factors for cardiotoxicity from anthracyclines and sequential anthracyclines and trastuzumab.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Guenancia, Lefebvre, Cardinale, Yu, Ladoire, Ghiringhelli, Zeller, Rochette, Cottin, Vergely Tags: Chemotherapy Breast Cancer Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chemotherapy | Diabetes | Eating Disorders & Weight Management | Endocrinology | Heart | Herceptin | Hypertension | Metabolic Syndrome | Obesity | Study